60505-4779 Pazopanib - CanMED: NDC

Product NDC:

60505-4779

Brand Name:

Pazopanib

Generic Name:

Pazopanib

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: PAZOPANIB

Strength: 200.0

Unit: mg/1

Packages:

Code: 60505-4779-05

Description: 500 TABLET in 1 BOTTLE (60505-4779-5)

Effective Date: Oct. 19, 2023

Discontinued:

Code: 60505-4779-07

Description: 120 TABLET in 1 BOTTLE (60505-4779-7)

Effective Date: Oct. 19, 2023

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

VEGFR, PDGFR, FGFR, Kit, Itk, Lck, c-Fms

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox